Aceragen | IDRA - Market Capitalization


Aceragen reported $3.2M in Market Capitalization this August of 2023, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Agenus USD 107M 16M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Amgen USD 176.25B 24.32B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
X T L Biopharmaceuticals USD 22M 8M Dec/2024